LIDDS
0.105
SEK
+5 %
LIDDS
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 following
+5%
+3.45%
+4.48%
+5%
-28.57%
-4.55%
-98.82%
-99.25%
-98.9%
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patent-protected and clinically tested drug delivery technology. The properties of the products form the basis of LIDDS 'technology platform for the development of injectable drug products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System and the company is headquartered in Uppsala.
Read moreMarket cap
14.33M SEK
Turnover
10.59K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
22.2
2025
Annual report '24
29.5
2025
General meeting '24
29.5
2025
Interim report Q1'25
ShowingAll content types
LIDDS AB (publ) Interim Report January – September 2024
LIDDS has decided to concentrate its activities on three project areas
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools